Vitestro lands EUR 64.81m as US strategics back phlebotomy automation
Dutch medical robotics company Vitestro raised EUR 64.81 million in an oversubscribed Series B, adding strategic investors including Labcorp Venture Fund, Mayo Clinic and Sutter Health. The round funds FDA De Novo work, manufacturing scale-up and commercial readiness for its autonomous blood-draw system.